- Accomplished Systems Biology Leader with over 15 years of professional industry experience in Drug and Target Discovery, as well as Translational and Precision Medicine. - Strategic visionary with a track record of conception and development of integrative analysis approaches and delivery of actionable results. - Multifaceted scientist capable of leading cross-functional, matrixed, and cross-continental teams internally and with external collaborations, partnerships, and KOLs. - Strong scientific program and project manager with proven ability to attract, retain, mentor and grow talent. Her personal and professional motivation has always been to make a difference in healthcare by aiding in delivery or development of more scientifically powered medicine. Specialized kills and areas of key strengths include: -Systems Therapeutics -Precision Oncology -Tumor Cell Biology -Drug Resistance Mechanisms in Cancer -Actionable Pathway Analysis -Multi-Omic Network Reconstruction -Target Identification and Prioritization -Clinical Trial Matching -Clinical Trial Data Analysis -Drug and Target Mechanism of Action (MoA) -Drug Repositioning -Companion Diagnostics -Cancer Diagnostics -Clinical Reporting -Systems Chemical Biology -Disease Etiology and Mechanistic Hypothesis -Patient Stratification -Safety and Tox Assessment -Biomarker Discovery -Integrated and Functional Genomics -Genotype-Phenotype Integration & Interpretation -Multi-Hit Genetic and Environmental Causal Disease Hypotheses -Multi-Scale Biology (genomics, proteomics, metabolomics, transcriptomics, epigenetics, etc., ...) -Cell Signaling / Signal Transduction / Pathway Cross-Talk / Converging Pathways/ Molecular Network Modeling/ Mechanistic Models / Pathway Activity and Target Activity Inference -Literature Curation & Content Management -Multidisciplinary Team Management -Product Development -Competitive Intelligence -Process Automation -Thought Leadership -Scientific and Technical Writing -Public Speaking